Determinants of New-Onset Diabetes Among 19,257 Hypertensive Patients Randomized in the Anglo-Scandinavian Cardiac Outcomes Trial–Blood Pressure Lowering Arm and the Relative Influence of Antihypertensive Medication

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663 · see citing works

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664 · see citing works

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Dahlöf, B., Sever, P. S., Poulter, N. R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G. T., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67185-1 · Cited by 2,909 · see citing works

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,546 · see citing works

Lifetime risk for diabetes mellitus in the United States

Narayan, K. M. V. (2003) · JAMA · doi:10.1001/jama.290.14.1884 · Cited by 1,515 · see citing works

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV

Williams, B., Poulter, N. R., Brown, M. J., Davis, M., McInnes, G. T., POTTER, J. F., Sever, P. S., & Thom, S. (2004) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001683 · Cited by 1,262 · see citing works

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)

Brown, M. J., Palmer, C. R., Castaigne, A., de Leeuw, P. W., Mancia, G., Rosenthal, T., & Ruilope, L. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02527-7 · Cited by 1,206 · see citing works

Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus

Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202 · see citing works

Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis

Elliott, W. J., & Meyer, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60108-1 · Cited by 1,016 · see citing works

Effect of ramipril on the incidence of diabetes

(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737 · see citing works

Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects

Verdecchia, P., Reboldi, G., Angeli, F., Borgioni, C., Gattobigio, R., Filippucci, L., Norgiolini, S., Bracco, C., & Porcellati, C. (2004) · Hypertension · doi:10.1161/01.hyp.0000125726.92964.ab · Cited by 510 · see citing works

Normal fasting plasma glucose levels and type 2 diabetes in young men

Tirosh, A., Shai, I., Tekes-Manova, D., Israeli, E., Pereg, D., Shochat, T., Kochba, I., & Rudich, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050080 · Cited by 508 · see citing works

Identifying Individuals at High Risk for Diabetes

Schmidt, M. I., Duncan, B. B., Bang, H., Pankow, J. S., Ballantyne, C. M., Golden, S. H., Folsom, A. R., Chambless, L. E., & for the Atherosclerosis Risk in Communities Investigators (2005) · Diabetes Care · doi:10.2337/diacare.28.8.2013 · Cited by 455 · see citing works

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00035 · Cited by 392 · see citing works

Metabolic outcome during 1 year in newly detected hypertensives

Lindholm, L. H., Persson, M., Alaupovic, P., Carlberg, B., Svensson, A., & Samuelsson, O. G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200308000-00022 · Cited by 353 · see citing works

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

Kostis, J. B., Wilson, A. C., Freudenberger, R. S., Cosgrove, N. M., Pressel, S. L., & Davis, B. R. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.059 · Cited by 325 · see citing works

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

Lindholm, L. H., Persson, M., Alaupovic, P., Carlberg, B., Svensson, A., & Samuelsson, O. G. (2003) · PubMed · doi:10.1097/01.hjh.0000084723.53355.76 · Cited by 308 · see citing works

New-onset diabetes and antihypertensive drugs

Mancia, G., Grassi, G. M., & Zanchetti, A. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000194119.42722.21 · Cited by 290 · see citing works

A Risk Score for Predicting Incident Diabetes in the Thai Population

Aekplakorn, W., Bunnag, P., Woodward, M., Sritara, P., Cheepudomwit, S., Yamwong, S., Yipintsoi, T., & Rajatanavin, R. (2006) · Diabetes Care · doi:10.2337/dc05-2141 · Cited by 275 · see citing works

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial

Sever, P., Dahlöf, B., Poulter, N. R., Wedel, H., Beevers, G., Caulfield, M. J., Collins, R., Kjeldsen, S. E., McInnes, G. T., Mehlsen, J., et al. (2001) · Journal of Hypertension · doi:10.1097/00004872-200106000-00020 · Cited by 264 · see citing works

Fasting Glucose Levels and Incident Diabetes Mellitus in Older Nondiabetic Adults Randomized to Receive 3 Different Classes of Antihypertensive Treatment

Barzilay, J. I. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2191 · Cited by 264 · see citing works

Alcohol consumption and type 2 diabetes: Meta-analysis of epidemiological studies indicates a U-shaped relationship

Carlsson, S., Hammar, N., & Grill, V. (2005) · Diabetologia · doi:10.1007/s00125-005-1768-5 · Cited by 239 · see citing works

Hyperglycemia and Glycosuria Due to Thiazide Derivatives Administered in Diabetes Mellitus

Goldner, M. G., Zarowitz, H., & Akgün, S. (1960) · New England Journal of Medicine · doi:10.1056/nejm196002252620807 · Cited by 209 · see citing works

A Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes

Padwal, R. S., Majumdar, S. R., Johnson, J. A., Varney, J., & McAlister, F. A. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.736 · Cited by 164 · see citing works

Alcohol Consumption and Risk for Development of Impaired Fasting Glucose or Type 2 Diabetes in Middle-Aged Japanese Men

Nakanishi, N., Suzuki, K., & Tatara, K. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.48 · Cited by 120 · see citing works

`Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)

McInnes, G. T. (2003) · The British Journal of Diabetes · doi:10.1177/14746514030030040501 · Cited by 117 · see citing works

Development of diabetes is retarded by ACE inhibition in hypertensive patients ??? a subanalysis of the Captopril Prevention Project (CAPPP)

Niklason, A., Hedner, T., NISKANEN, L. K., & Lanke, J. (2004) · Journal of Hypertension · doi:10.1097/00004872-200403000-00029 · Cited by 91 · see citing works

Angiotensin–sympathetic system interactions in cardiovascular and metabolic disease

Mancia, G., Dell’Oro, R., Quarti‐Trevano, F., Scopelliti, F., & Grassi, G. M. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220407.84363.fb · Cited by 72 · see citing works

Incidence and outcomes of diabetes mellitus in elderly people: report from the Canadian Study of Health and Aging.

Rockwood, K. J., Awalt, E., MacKnight, C., & McDowell, I. (2000) · Europe PMC (PubMed Central) · Cited by 54 · see citing works

Differing Effects of Antihypertensive Drugs on the Incidence of Diabetes Mellitus Among Patients With Hypertensive Kidney Disease

Thornley‐Brown, D. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.797 · Cited by 42 · see citing works

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial

Aksnes, T. A., Kjeldsen, S. E., Rostrup, M., Störset, Ö., Hua, T., & Julius, S. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.41 · Cited by 33 · see citing works

Glucose and cholesterol elevations during thiazide therapy: Intention-to-treat versus actual on-therapy experience

Elliott, W. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80158-2 · Cited by 29 · see citing works

Antihypertensive-Associated Incident Diabetes: Controversy Persists

Gupta, A. K., & Poulter, N. R. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.13.1433-a · Cited by 2 · see citing works

Untitled work

Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly

Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821daaf6 · Cited by 619 · see citing works

Obesity‐Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of <i>The Obesity Society</i> and the <i>American Society of Hypertension</i>

Landsberg, L., Aronne, L. J., Beilin, L. J., Burke, V., Igel, L. I., Lloyd‐Jones, D., & Sowers, J. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12049 · Cited by 528 · see citing works

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly

Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 511 · see citing works

Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting

Collins, G. S., Mallett, S., Omar, O., & Yu, L.-M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-103 · Cited by 484 · see citing works

Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin

Waters, D. D., Ho, J. E., DeMicco, D. A., Breazna, A., Arsenault, B. J., Wun, C.-C., Kastelein, J. J., Colhoun, H., & Barter, P. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.047 · Cited by 333 · see citing works

Obesity‐related hypertension: Pathogenesis, cardiovascular risk, and treatment—A position paper of the The Obesity Society and the American Society of Hypertension

Landsberg, L., Aronne, L. J., Beilin, L. J., Burke, V., Igel, L. I., Lloyd‐Jones, D. M., & Sowers, J. R. (2012) · Obesity · doi:10.1002/oby.20181 · Cited by 286 · see citing works

Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years

Kahn, H. S., Cheng, Y. J., Thompson, T. J., Imperatore, G., & Gregg, E. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00002 · Cited by 204 · see citing works

Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance?

Li, N., Fu, J., Koonen, D. P. Y., Kuivenhoven, J. A., Snieder, H., & Hofker, M. H. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.013 · Cited by 177 · see citing works

Effects of β-blockers on glucose and lipid metabolism

Fonseca, V. A. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903533681 · Cited by 159 · see citing works

ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly

Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G. L., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C. S., et al. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.06.001 · Cited by 151 · see citing works

Blood pressure control in type 2 diabetic patients

Grossman, A., & Grossman, E. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0485-3 · Cited by 134 · see citing works

Improving Type 2 Diabetes Through a Distinct Adrenergic Signaling Pathway Involving mTORC2 That Mediates Glucose Uptake in Skeletal Muscle

Sato, M., Dehvari, N., Öberg, A. I., Dallner, O. S., Sandström, A. L., Olsen, J. M., Csikasz, R. I., Summers, R. J., Hutchinson, D. S., & Bengtsson, T. (2014) · Diabetes · doi:10.2337/db13-1860 · Cited by 130 · see citing works

Blood Pressure and the Risk of Developing Diabetes in African Americans and Whites

Wei, G. S., Coady, S., Goff, D. C., Brancati, F. L., Levy, D. A., Selvin, E., Vasan, R. S., & Fox, C. S. (2011) · Diabetes Care · doi:10.2337/dc10-1786 · Cited by 127 · see citing works

Risk of new-onset diabetes mellitus in primary aldosteronism

Wu, V., Chueh, S., Chen, L., Chang, C., Hu, Y., Lin, Y., Wu, K., & Yang, W. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001361 · Cited by 106 · see citing works

Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population

He, S., Wang, S., Chen, X., Jiang, L., Peng, Y., Li, L., Wan, L., & Cui, K. (2011) · Metabolism · doi:10.1016/j.metabol.2011.05.007 · Cited by 106 · see citing works

Hypertension in Metabolic Syndrome: Novel Insights

Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415161813 · Cited by 103 · see citing works

Genetic Predisposition to Dyslipidemia and Type 2 Diabetes Risk in Two Prospective Cohorts

Qi, Q., Liang, L., Doria, A., Hu, F. B., & Qi, L. (2012) · Diabetes · doi:10.2337/db11-1254 · Cited by 100 · see citing works

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

DiNicolantonio, J. J., Fares, H., Niazi, A. K., Chatterjee, S., D’Ascenzo, F., Cerrato, E., Biondi‐Zoccai, G., Lavie, C. J., Bell, D. S. H., & O’Keefe, J. H. (2015) · Open Heart · doi:10.1136/openhrt-2014-000230 · Cited by 101 · see citing works

Effect of Doxazosin Gastrointestinal Therapeutic System as Third-Line Antihypertensive Therapy on Blood Pressure and Lipids in the Anglo-Scandinavian Cardiac Outcomes Trial

Chapman, N., Chang, C. L., Dahlöf, B., Sever, P., Wedel, H., & Poulter, N. R. (2008) · Circulation · doi:10.1161/circulationaha.107.737957 · Cited by 99 · see citing works

Mendelian Randomization Studies Do Not Support a Role for Raised Circulating Triglyceride Levels Influencing Type 2 Diabetes, Glucose Levels, or Insulin Resistance

Silva, N. M. G. D., Freathy, R. M., Palmer, T., Donnelly, L. A., Luan, J., Gaunt, T. R., Langenberg, C., Weedon, M. N., Shields, B. M., Knight, B. A., et al. (2011) · Diabetes · doi:10.2337/db10-1317 · Cited by 91 · see citing works

Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities

Przezak, A., Bielka, W., & Pawlik, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126500 · Cited by 91 · see citing works

Is Pulse Pressure a Predictor of New-Onset Diabetes in High-Risk Hypertensive Patients?

Yasuno, S., Ueshima, K., Oba, K., Fujimoto, A., Hirata, M., Ogihara, T., Saruta, T., & Nakao, K. (2010) · Diabetes Care · doi:10.2337/dc09-1447 · Cited by 81 · see citing works

Systolic Blood Pressure and Risk of Type 2 Diabetes: A Mendelian Randomization Study

Aikens, R. C., Zhao, W., Saleheen, D., Reilly, M. P., Epstein, S. E., Tikkanen, E., Salomaa, V. V., & Voight, B. F. (2016) · Diabetes · doi:10.2337/db16-0868 · Cited by 72 · see citing works

Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials

Hsue, P. Y., Bittner, V., Betteridge, J. D., Fayyad, R. S., Laskey, R. E., WENGER, N. K., & Waters, D. D. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.11.026 · Cited by 60 · see citing works

Statin Treatment, New-Onset Diabetes, and Other Adverse Effects: A Systematic Review

Bang, C. N., & Okin, P. M. (2014) · Current Cardiology Reports · doi:10.1007/s11886-013-0461-4 · Cited by 56 · see citing works

Effects of calcium channel blockers on glucose tolerance, inflammatory state, and circulating progenitor cells in non-diabetic patients with essential hypertension: a comparative study between Azelnidipine and amlodipine on Glucose tolerance and ENdothelial function - a crossover Trial (AGENT)

Fukao, K., Shimada, K., Hiki, M., Kiyanagi, T., Hirose, K., Kume, A., Ohsaka, H., Matsumori, R., Kurata, T., Miyazaki, T., et al. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-79 · Cited by 55 · see citing works

Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

Kristensen, A. M. D., Bovin, A., Zwisler, A., Cerquira, C., Torp-Pedersen, C. T., Bøtker, H. E., Gustafsson, I., Veien, K. T., Thomsen, K. K., Olsen, M. H., et al. (2020) · Trials · doi:10.1186/s13063-020-4214-6 · Cited by 53 · see citing works

Cardiovascular Therapies and Associated Glucose Homeostasis

Cooper‐DeHoff, R. M., Pacanowski, M. A., & Pepine, C. J. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.037 · Cited by 53 · see citing works

Time to re-appraise the role of alpha-1 adrenoceptor antagonists in the management of hypertension?

Chapman, N., Chen, C.-Y., Fujita, T., Hobbs, R. F., Kim, S., Staessen, J. A., Tanomsup, S., Wang, J., & Williams, B. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833b912c · Cited by 49 · see citing works

Association between unfavorable lipid profile and glycemic control in patients with type 2 diabetes mellitus

Klisic, A. N., Kavarić, N., Jovanović, M., Zvrko, E. Z., Skerovic, V., Scepanovic, A., Medin, D., & Ninić, A. (2017) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_284_17 · Cited by 49 · see citing works

Myocardial metabolism in heart failure: Purinergic signalling and other metabolic concepts

Birkenfeld, A. L., Jordan, J., Dworak, M., Merkel, T., & Burnstock, G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.015 · Cited by 45 · see citing works

Are visceral adiposity index and lipid accumulation product reliable indices for metabolic disturbances in patients with type 2 diabetes mellitus?

Kavarić, N., Klisic, A. N., & Ninić, A. (2017) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22283 · Cited by 43 · see citing works

A prediction nomogram for the 3-year risk of incident diabetes among Chinese adults

Wu, Y., Hu, H., Cai, J., Chen, R., Zuo, X., Cheng, H. W., & Yan, D. (2020) · Scientific Reports · doi:10.1038/s41598-020-78716-1 · Cited by 42 · see citing works

Blood Pressure Control and the Association With Diabetes Mellitus Incidence

Roumie, C. L., Hung, A. M., Russell, G. B., Basile, J., Kreider, K. E., Nord, J. W., Ramsey, T., Rastogi, A., Sweeney, M. E., Tamariz, L. J., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12572 · Cited by 42 · see citing works

Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China

Wang, S., Ji, X., Zhang, Z., & Xue, F. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17155317 · Cited by 42 · see citing works

Further data on beta-blockers and cancer risk: observational study and meta-analysis of randomized clinical trials

Monami, M., Filippi, L., Ungar, A., Sgrilli, F., Antenore, A., Dicembrini, I., Bagnoli, P., Marchionni, N., Rotella, C. M., & Mannucci, E. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.772505 · Cited by 40 · see citing works

Erectile dysfunction in heart failure patients: a critical reappraisal

Alberti, L., Torlasco, C., Lauretta, L., Loffi, M., Maranta, F., Salonia, A., Margonato, A., Montorsi, F., & Fragasso, G. (2013) · Andrology · doi:10.1111/j.2047-2927.2012.00048.x · Cited by 37 · see citing works

Antihypertensive medications: benefits of blood pressure lowering and hazards of metabolic effects

Karnes, J. H., & Cooper‐DeHoff, R. M. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.09.31 · Cited by 37 · see citing works

Combining Other Antihypertensive Drugs With β-Blockers in Hypertension: A Focus on Safety and Tolerability

Richards, T. R., & Tobe, S. W. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.08.012 · Cited by 34 · see citing works

Statins and diabetes risk: Fact, fiction, and clinical implications

Rocco, M. B. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.12091 · Cited by 32 · see citing works

Erratum: Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study

Jacobs, S., Schiller, K., Jansen, E. H. J. M., Fritsche, A., Weikert, C., di Giuseppe, R., Boeing, H., Schulze, M. B., & Kröger, J. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.36 · Cited by 32 · see citing works

Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study

Jacobs, S., Schiller, K., Jansen, E. H. J. M., Fritsche, A., Weikert, C., di Giuseppe, R., Boeing, H., Schulze, M. B., & Kröger, J. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.18 · Cited by 30 · see citing works

The current status of beta blockers’ use in the management of hypertension

Akbar, S., & Alorainy, M. S. (2014) · Saudi Medical Journal · doi:10.15537/1658-3175.6072 · Cited by 29 · see citing works

Prevention of heart failure in the elderly: when, where and how to begin?

Jugdutt, B. I. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9299-x · Cited by 26 · see citing works

Optimizing the treatment of hypertension and stable coronary artery disease: clinical evidence for fixed-combination perindopril/amlodipine

Ferrari, R. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802576302 · Cited by 28 · see citing works

Mendelian Randomization and Type 2 Diabetes

Swerdlow, D. I. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6638-5 · Cited by 27 · see citing works

Beta-blockers in Cardiovascular Therapy: A Review

Diaconu, C., Marcu, D., Bratu, O. G., Stănescu, A. M. A., Gheorghe, G., Hleșcu, A. A., Mischianu, D. L. D., & Manea, M. M. (2019) · Journal of Mind and Medical Sciences · doi:10.22543/7674.62.p216223 · Cited by 27 · see citing works

American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two

Bloomgarden, Z. T. (2008) · Diabetes Care · doi:10.2337/dc08-zb11 · Cited by 26 · see citing works

Causal Graph Among Serum Lipids and Glycemic Traits: A Mendelian Randomization Study

Zhu, Z., Wang, K., Hao, X., Chen, L., Liu, Z., & Wang, C. (2022) · Diabetes · doi:10.2337/db21-0734 · Cited by 26 · see citing works

Association of TG / HDLC ratio trajectory and risk of type 2 diabetes: A retrospective cohort study in China

Zhang, Y., Qin, P., Lou, Y., Zhao, P., Li, X., Qie, R., Wu, X., Han, M., Huang, S., Zhao, Y., et al. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13123 · Cited by 25 · see citing works

Are two drugs better than one? A review of combination therapies for hypertension

Rochlani, Y. M., Khan, M. H., Banach, M., & Aronow, W. S. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1288719 · Cited by 25 · see citing works

Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension

Mancia, G., Coca, A., Chazova, I. E., Girerd, X. J., Haller, H. G., Pauletto, P., Pupek‐Musialik, D., & Svyshchenko, Y. (2014) · Journal of Hypertension · doi:10.1097/hjh.0000000000000239 · Cited by 24 · see citing works

Causal Association of Obesity and Dyslipidemia with Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

Lee, Y., Kim, Y. A., & Seo, J. H. (2022) · Genes · doi:10.3390/genes13122407 · Cited by 24 · see citing works

Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with Hypertension

da Silva, P. M. (2010) · Clinical Drug Investigation · doi:10.2165/11538440-000000000-00000 · Cited by 23 · see citing works

Calcium antagonists in the treatment of coronary artery disease

Cooper‐DeHoff, R. M., Chang, S.-W., & Pepine, C. J. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.01.008 · Cited by 23 · see citing works

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT‐BPLA: comparison of their relative predictability using a novel approach

Gupta, A. K., Prieto‐Merino, D., Dahlöf, B., Sever, P., Poulter, N. R., & on behalf of the ASCOT Investigators (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03330.x · Cited by 22 · see citing works

Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine

Burnier, M. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3510 · Cited by 22 · see citing works

Short- and Long-Term Survival in Treated Elderly Hypertensive Patients With or Without Diabetes: Findings From the Second Australian National Blood Pressure Study

Chowdhury, E., Owen, A. J., Ademi, Z., Krum, H., Johnston, C. I., Wing, L. M. H., Nelson, M. R., & Reid, C. M. (2013) · American Journal of Hypertension · doi:10.1093/ajh/hpt212 · Cited by 21 · see citing works

Comparing six antihypertensive medication classes for preventing new‐onset diabetes mellitus among hypertensive patients: a network meta‐analysis

Yang, Y., & Xu, H. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13096 · Cited by 21 · see citing works

Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders

Zakynthinos, G. Ε., Tsolaki, V., Oikonomou, E. K., Vavouranakis, M., Siasos, G., & Zakynthinos, E. G. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091323 · Cited by 22 · see citing works

Unexplained reciprocal regulation of diabetes and lipoproteins

Higuchi, S., Izquierdo, M. C., & Haeusler, R. A. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000521 · Cited by 21 · see citing works

Cost–Utility of Angiotensin-Converting Enzyme Inhibitor-Based Treatment Compared With Thiazide Diuretic-Based Treatment for Hypertension in Elderly Australians Considering Diabetes as Comorbidity

Chowdhury, E., Ademi, Z., Moss, J. R., Wing, L. M. H., & Reid, C. M. (2015) · Medicine · doi:10.1097/md.0000000000000590 · Cited by 20 · see citing works

Vascular Surgery Kidney Injury Predictive Score: A Historical Cohort Study

KASHANI, K. B., Steuernagle, J., Akhoundi, A., Alsara, A., Hanson, A. C., & Kor, D. J. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.04.013 · Cited by 20 · see citing works

Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis

Zhao, H., Li, Y., Liu, S.-M., Sun, X.-G., Li, M., Yan, H., Cui, L., & Wang, A. (2016) · Renal Failure · doi:10.3109/0886022x.2016.1165065 · Cited by 19 · see citing works

The Causal Relationship of Circulating Triglyceride and Glycated Hemoglobin: A Mendelian Randomization Study

Hsiung, C., Chang, Y., Lin, C.-W., Chang, C.-W., Chou, W., Chu, H., Su, M., Wu, P., & Shen, C. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz243 · Cited by 19 · see citing works

Evidence for benefits of angiotensin receptor blockade beyond blood pressure control

Siragy, H. M. (2008) · Current Hypertension Reports · doi:10.1007/s11906-008-0050-x · Cited by 19 · see citing works

Comparative risk of new‐onset diabetes mellitus for antihypertensive drugs: A network meta‐analysis

Li, Z., Li, Y., Liu, Y., Xu, W., & Wang, Q. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.13108 · Cited by 17 · see citing works

Beta-adrenergic blockade increases GLUT4 and improves glycemic control in insulin-treated diabetic Wistar rats

Alves-Wagner, A. B., Mori, R. C. T., Silva, R. S., de Fátima, L. A., Alves, A. D. S., Britto, L. R., Schaan, B. D., & Machado, U. F. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.10.003 · Cited by 17 · see citing works

Association between high-density lipoprotein cholesterol and type 2 diabetes mellitus among Chinese: the Beijing longitudinal study of aging

Cao, X., Tang, Z., Zhang, J., Li, H., Singh, M., Sun, F., Li, X., Li, C., Wang, Y., Guo, X., et al. (2021) · Lipids in Health and Disease · doi:10.1186/s12944-021-01499-5 · Cited by 16 · see citing works

Hypertriglyceridemia is associated with development of metabolic glucose disorders, irrespective of glucose and insulin levels: A 15-year follow-up study

Guerrero‐Romero, F., & Rodríguez‐Morán, M. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.01.015 · Cited by 16 · see citing works

Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence

McGill, J. B. (2010) · Vascular Health and Risk Management · doi:10.2147/vhrm.s6668 · Cited by 16 · see citing works

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease

Basile, J. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02009.x · Cited by 15 · see citing works

Risk of new-onset diabetes mellitus associated with beta-blocker treatment for hypertension

Fonseca, V. A., Sharma, P. P., Shah, M. B., & DEEDWANIA, P. C. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.555477 · Cited by 15 · see citing works

Improving blood pressure control rates by optimizing combination antihypertensive therapy

Epstein, B. J. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.500614 · Cited by 14 · see citing works

Association of mean arterial pressure with 5-year risk of incident diabetes in Chinese adults：a secondary population-based cohort study

Wu, Y., Hu, H., Cai, J., Chen, R., Zuo, X., Cheng, H. W., & Yan, D. (2022) · BMJ Open · doi:10.1136/bmjopen-2020-048194 · Cited by 14 · see citing works

Melatonin Pathway and Atenolol‐Related Glucose Dysregulation: Is There a Correlation?

Chang, S., Gong, Y., McDonough, C. W., Langaee, T. Y., Nasiri‐Kenari, N., Beitelshees, A., Gums, J. G., Chapman, A., Turner, S., Johnson, J. A., et al. (2016) · Clinical and Translational Science · doi:10.1111/cts.12389 · Cited by 14 · see citing works

Positive association of serum uric acid with new‐onset diabetes in Chinese women with hypertension in a retrospective analysis of the China Stroke Primary Prevention Trial

Zhou, C., Liu, M., Zhang, Z., Zhang, Y., Nie, J., Liang, M., Liu, C., Hu, W., Song, Y., Liu, L., et al. (2020) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14072 · Cited by 14 · see citing works

Antihypertensive Drugs and New‐Onset Diabetes: A Retrospective Longitudinal Cohort Study

Jong, G., Chang, M., Tien, L., Li, S., Liou, Y., Lung, C., & Ma, T. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2009.00092.x · Cited by 13 · see citing works

Pathophysiologic therapeutic targets in hypertension: a cardiological point of view

Fragasso, G., Maranta, F., Montanaro, C., Salerno, A., Torlasco, C., & Margonato, A. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.655724 · Cited by 14 · see citing works

Genetically Mediated Lipid Metabolism and Risk of Insulin Resistance: Insights from Mendelian Randomization Studies

Bu, S. Y. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.132 · Cited by 13 · see citing works

Agreement between Type 2 Diabetes Risk Scales in a Caucasian Population: A Systematic Review and Report

Ayensa-Vazquez, J. A., Leiva, A., Tauler, P., López‐González, Á. A., Aguiló, A., Salvá, M. T., & Bennasar‐Veny, M. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051546 · Cited by 13 · see citing works

Blood pressure and diabetes: a fatal attraction

Williams, B. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht365 · Cited by 13 · see citing works

A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients

García‐Donaire, J. A., Segura, J., Cerezo, C., & Ruilope, L. M. (2011) · Blood Pressure · doi:10.3109/08037051.2011.602878 · Cited by 12 · see citing works

The Results of ACES (Antihypertensive Combinations’ Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies

Nádházi, Z., & Dézsi, C. A. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0431-x · Cited by 12 · see citing works

Regional Variation in Comorbid Prediabetes and Diabetes and Associated Factors among Hypertensive Individuals in Rural Bangladesh, Pakistan, and Sri Lanka

Feng, L., Naheed, A., de Silva, H. A., Jehan, I., Raqib, R., Islam, M. T., Luke, N. V., Kasturiratne, A., Farazdaq, H., Senan, S., et al. (2019) · Journal of Obesity · doi:10.1155/2019/4914158 · Cited by 13 · see citing works

Combinations of inhibitors of the renin–angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine

Mourad, J., Jeune, S. L., Pirollo, A., Mourad, C., Gaudouen, Y., & Lopez‐Sublet, M. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.510925 · Cited by 12 · see citing works

New-onset diabetes and cardiovascular events in essential hypertensives: A 6-year follow-up study

Tsiachris, D., Tsioufis, C. P., Thomopoulos, C., Syrseloudis, D., Antonakis, V., Lioni, L., Kallikazaros, I. E., Makris, T. K., Papademetriou, V., & Stefanadis, C. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.08.041 · Cited by 10 · see citing works

Pathophysiological Mechanisms and Correlates of Therapeutic Pharmacological Interventions in Essential Arterial Hypertension

Maranta, F., Spoladore, R., & Fragasso, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_169 · Cited by 11 · see citing works

Genome-wide association study identifies pharmacogenomic loci linked with specific antihypertensive drug treatment and new-onset diabetes

Chang, S.-W., McDonough, C. W., Gong, Y., Johnson, T. A., Tsunoda, T., Gamazon, E. R., Perera, M. A., Takahashi, A., Tanaka, T., Kubo, M., et al. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.67 · Cited by 9 · see citing works

Treating hypertension in type 2 diabetes

Grossman, Y., Shlomai, G., & Grossman, E. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.947267 · Cited by 9 · see citing works

Dysglycaemia in non-diabetic hypertensive patients: comparison of the impact of two different classifications of impaired fasting glucose on the cardiovascular risk profile

Dell’Omo, G., Penno, G., Prato, S. D., Mariani, M., & Pedrinelli, R. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.142 · Cited by 9 · see citing works

Alteration in fasting glucose after prolonged treatment with a thiazide diuretic

Karnes, J. H., Gong, Y., Arwood, M. J., Gums, J. G., Hall, K., Limacher, M. C., Johnson, J. A., & Cooper‐DeHoff, R. M. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.004 · Cited by 9 · see citing works

Misclassification in assessment of diabetogenic risk using electronic health records

Winterstein, A. G., Kubilis, P. S., Bird, S. T., Cooper‐DeHoff, R. M., Nichols, G. A., & Delaney, J. A. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3656 · Cited by 8 · see citing works

Which patients benefit the most from the perindopril/amlodipine combination

Mourad, J. (2011) · Journal of Hypertension · doi:10.1097/01.hjh.0000410249.82091.50 · Cited by 8 · see citing works

Low prevalence of type 2 diabetes mellitus among patients with high levels of high-density lipoprotein cholesterol

Juren, A. J., Sarwal, G., Al-Sarraf, A. J., Vrablı́k, M., Chan, D., Humphries, K. H., & Frohlich, J. J. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.02.003 · Cited by 8 · see citing works

Thiazide-induced dysglycemia: it’s time to take notice

Cooper‐DeHoff, R. M. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.10.1291 · Cited by 8 · see citing works

The “Weight” of Obesity on Arterial Hypertension

Noce, A., & Daniele, N. D. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87774 · Cited by 7 · see citing works

Hypertension and diabetes incidence: confounding factors

Cicero, A. F. G., & Ertek, S. (2011) · Hypertension Research · doi:10.1038/hr.2011.94 · Cited by 7 · see citing works

Derivation and validation of a simple risk score for undiagnosed diabetes for Tanzania and other African populations

Mayige, M. T. (2014) · Cited by 7 · see citing works

Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease

Shavadia, J., Zheng, Y., Green, J. B., Armstrong, P. W., Westerhout, C. M., McGuire, D. K., Cornel, J. H., Holman, R. R., & Peterson, E. D. (2019) · American Heart Journal · doi:10.1016/j.ahj.2019.09.013 · Cited by 6 · see citing works

Progress in Clinical TrialsASCOT-BPLA Trial (determinants of new onset diabetes among hypertensive patients randomized in the ASCOT-BPLA trial)

(2006) · Clinical Cardiology · doi:10.1002/clc.20033

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial

Aksnes, T. A., Kjeldsen, S. E., Rostrup, M., Störset, Ö., Hua, T., & Julius, S. (2008) · Journal of Human Hypertension · doi:10.1038/jhh.2008.41 · Cited by 33 · see citing works

Antihypertensive Drugs and New‐Onset Diabetes: A Retrospective Longitudinal Cohort Study

Jong, G., Chang, M., Tien, L., Li, S., Liou, Y., Lung, C., & Ma, T. (2009) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2009.00092.x · Cited by 13 · see citing works

Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study

Lindholm, L. H., Ibsen, H., Borch-Johnsen, K., Olsen, M. H., Wachtell, K., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200209000-00035 · Cited by 392 · see citing works

Impact of hypertension on development of new-onset diabetes mellitus in Asian population: five-year clinical follow up results

Park, Y., Rha, S., Choi, B. G., Choi, S. Y., Choi, C. U., Kim, E. J., Park, C. G., Seo, H. S., Oh, D. J., & Park, S.-Y. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht310.4460